Westerville, OH, United States of America

David A Borror


Average Co-Inventor Count = 5.6

ph-index = 3

Forward Citations = 177(Granted Patents)


Company Filing History:


Years Active: 2000-2001

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Innovations of David A. Borror in Reducing Necrotizing Enterocolitis

Introduction

David A. Borror, an inventor based in Westerville, Ohio, has made significant contributions in the field of healthcare through his innovative ideas and solutions. With a portfolio that includes three patents, he has focused on methods that aim to improve neonatal health, particularly in reducing the incidence of necrotizing enterocolitis (NEC).

Latest Patents

Borror's latest patents focus on enteral formulas that contain long-chain polyunsaturated fatty acids (PUFAs) such as arachidonic acid (AA) and docosahexaenoic acid (DHA), which are designed to be essentially free of cholesterol. One of the notable patents describes compositions derived from egg yolk lipids, preferred for their rich content of omega-6 and omega-3 long-chain PUFAs, predominantly in a phosphatidylcholine form. This formulation aims to provide a synergistic effect that can significantly reduce the occurrence of NEC, showcasing Borror's dedication to innovative healthcare solutions.

Career Highlights

David A. Borror is associated with Abbott Laboratories Corporation, a prominent healthcare company known for its commitment to developing medical products and nutritional solutions. His work at Abbott has allowed him to contribute to groundbreaking research aimed at improving infant nutrition and health outcomes.

Collaborations

Throughout his career, Borror has collaborated with notable professionals, including Debra L. Ponder and Margaret H. Dohnalek. These collaborations have likely fostered an environment of innovation and knowledge sharing, leading to the development of effective healthcare solutions that can positively impact neonatal care.

Conclusion

David A. Borror has made remarkable strides in the field of healthcare innovation, particularly in the area of preventing necrotizing enterocolitis through his patented methods. His work at Abbott Laboratories Corporation and collaborations with esteemed colleagues underscore the importance of teamwork in driving medical advancements. Borror's contributions continue to shape the future of neonatal health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…